Is SUSRF or ORCC a better dividend investment in 2026?

SUSRF currently yields 70.42% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: SUSRF offers higher current income.

What is the dividend yield difference between SUSRF and ORCC?

SUSRF has a forward dividend yield of 70.42% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 60.63 percentage points.

Home › Compare › SUSRF vs ORCC

SUSRF vs ORCC: Dividend Comparison 2026

SUSRF yields 70.42% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SUSRF wins by $1.05M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SUSRF

● Live price

70.42%

Share price

$2.84

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.07M

Annual income

$282,657.96

Full SUSRF calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — SUSRF vs ORCC

📍 SUSRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SUSRF	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SUSRF + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SUSRF pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SUSRF

Annual income on $10K today (after 15% tax)

$5,985.92/yr

After 10yr DRIP, annual income (after tax)

$240,259.27/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, SUSRF beats the other by $240,258.38/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SUSRF + ORCC for your $10,000?

SUSRF: 50%ORCC: 50%

100% ORCC50/50100% SUSRF

Portfolio after 10yr

$546.8K

Annual income

$141,329.50/yr

Blended yield

25.85%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

SUSRF

No analyst data

Altman Z

2.7

Piotroski

6/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SUSRF buys

ORCC buys

No recent congressional trades found for SUSRF or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSUSRFORCC

Forward yield	70.42% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$1.07M	$21.4K ✓
Annual income after 10y	$282,657.96 ✓	$1.04
Total dividends collected	$914.3K ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: SUSRF vs ORCC ($10,000, DRIP)

Year	SUSRF Portfolio	SUSRF Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$17,742	$7,042.25	$11,190	$489.61	+$6.6K → SUSRF
2	$30,661	$11,677.14	$12,229	$256.01	+$18.4K → SUSRF
3	$51,667	$18,859.73	$13,216	$130.74	+$38.5K → SUSRF
4	$84,985	$29,701.39	$14,207	$66.02	+$70.8K → SUSRF
5	$136,593	$45,658.47	$15,234	$33.17	+$121.4K → SUSRF
6	$214,738	$68,583.71	$16,317	$16.62	+$198.4K → SUSRF
7	$330,537	$100,766.97	$17,468	$8.32	+$313.1K → SUSRF
8	$498,633	$144,958.95	$18,695	$4.16	+$479.9K → SUSRF
9	$737,910	$204,372.63	$20,006	$2.08	+$717.9K → SUSRF
10	$1,072,222	$282,657.96	$21,407	$1.04	+$1.05M → SUSRF

SUSRF vs ORCC: Complete Analysis 2026

SUSRF — Stock

Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.

Full SUSRF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this SUSRF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SUSRF vs SCHD SUSRF vs JEPI SUSRF vs O SUSRF vs KO SUSRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.